GLI3 and acute myeloid leukemia: A recent study shows that the activity of Hedgehog pathway is largely independent of Smo and therefore inherently resistant to Smo inhibitors in AML, and hypomethylating agent improves glasdegib sensitivity by increasing the level of Gli-3 repressor and modulation of Gli-1 [71].